More Americans die from DVT than
breast cancer, AIDS and traffic
Patients are at the highest risk
5-10 days post surgery
VTE is a leading cause of
preventable hospital deaths in
Financial impact rising costs for patient readmittance for DVT or associated wound care from device usage is growing.
Patient safety adverse drug events, bleeding risks of anti-coagulants can be mitigated by mechanical prophylaxis as stated by the Joint Commission.
Patient are at the highest risk 5-10 days post surgery for DVT. Patient compliance at home is the largest gap in all healthcare. Providing a solution for in home use is the future of post surgery care.
We are the #1 Standard of Care for DVT Prevention, providing hospitals the most efficient DVT program nationwide by decreasing your workload, increasing patient outcomes and providing the most compliant program for your hospital.
With a portable sequential device, hospitals can now discharge their patients faster. The average in-patient stay costs a hospital $2500 per day and up to $150 per hour.
Studies show that when a portable sequential device is used in a home setting, readmission rates for blood clots decrease in hospitals.
Tubeless and single patient devices will reduce the hospital acquired condition rates by decreasing fall risk and infection from contaminated pumps and prevent a patient from tripping over the tubes.
Hospital grade units that weigh up to 7 lbs. require SPD / infection control to wipe down the units with an alcohol wipe and usually clean bag the unit between patients.
Materials managers spend 25% of their time tracking pumps, managing reprocessing bins, replacing tubes, and sending the device for repairs. Circul8 is single patient use and travels home with the patient.
Hospitals typically spend $15-$65 per patient on new cuffs. Current ASP for a hospital and Circul8 will be negotiated. However, hospital will not have hidden costs of $50 for lost tubing, fines for lost pumps, Bio Med repair, labor costs, and manufacturer service costs.
Custom Patient Portal for increased patient compliance and increased outcomes.
The Circul8 is intended to be an easy to use portable system, prescribed by a physician, for use in the home or clinical setting to help prevent the onset of DVT in patients by stimulating blood flow in the extremities (stimulating muscle contractions). This device can be used to:
The DVT rate for the post-discharge protocol of Aspirin and Portable Mechanical Compression therapy group was 0%…
Learn More →
In patients undergoing total hip arthroplasty (THA) or total knee arthroplasty (TKA), we recommend use of one of the following…
We suggest the use of pharmacologic agents and/or mechanical compressive devices for the prevention of venous….